Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

Tamanna Haque, Félix López Cadenas, Blanca Xicoy, Ana Alfonso Piérola, Uwe Platzbecker, Irit Avivi, Andrew M. Brunner, Jöerg Chromik, Daniel Morillo, Manish R. Patel, José Falantes, Heather A. Leitch, Ulrich Germing, Meir Preis, Laurie Lenox, Josh Lauring, Regina J. Brown, Anna Kalota, Jaydeep Mehta, Friederike Pastore, Junchen Gu, Pankaj Mistry, David Valcárcel